Allianz Asset Management GmbH Increases Stake in Veradigm Inc. (NASDAQ:MDRX)

Allianz Asset Management GmbH lifted its stake in Veradigm Inc. (NASDAQ:MDRXFree Report) by 41.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 343,433 shares of the software maker’s stock after purchasing an additional 100,275 shares during the quarter. Allianz Asset Management GmbH owned about 0.31% of Veradigm worth $3,603,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of MDRX. Pacer Advisors Inc. raised its position in shares of Veradigm by 108.1% in the 4th quarter. Pacer Advisors Inc. now owns 2,516,574 shares of the software maker’s stock valued at $26,399,000 after purchasing an additional 1,307,024 shares during the last quarter. Wellington Management Group LLP raised its position in shares of Veradigm by 92.5% in the 3rd quarter. Wellington Management Group LLP now owns 2,665,814 shares of the software maker’s stock valued at $35,029,000 after purchasing an additional 1,281,319 shares during the last quarter. William Blair Investment Management LLC increased its holdings in Veradigm by 16.6% in the 3rd quarter. William Blair Investment Management LLC now owns 4,375,005 shares of the software maker’s stock worth $57,488,000 after buying an additional 623,438 shares during the period. Creative Planning increased its holdings in Veradigm by 2,848.4% in the 3rd quarter. Creative Planning now owns 474,376 shares of the software maker’s stock worth $6,233,000 after buying an additional 458,287 shares during the period. Finally, abrdn plc acquired a new position in Veradigm in the 4th quarter worth approximately $4,496,000.

Wall Street Analysts Forecast Growth

MDRX has been the topic of several research reports. StockNews.com initiated coverage on shares of Veradigm in a report on Sunday, June 2nd. They issued a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $10.00 price target (down previously from $15.00) on shares of Veradigm in a report on Tuesday, March 19th. Finally, TD Cowen cut their price target on shares of Veradigm from $26.00 to $15.00 and set a “buy” rating on the stock in a report on Tuesday, May 28th. Five equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, Veradigm has a consensus rating of “Hold” and a consensus target price of $12.00.

View Our Latest Research Report on MDRX

Veradigm Stock Down 0.5 %

Shares of NASDAQ MDRX opened at $9.50 on Friday. Veradigm Inc. has a 12 month low of $5.01 and a 12 month high of $14.09. The firm’s 50 day simple moving average is $8.04 and its 200-day simple moving average is $8.92.

Veradigm Profile

(Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Recommended Stories

Institutional Ownership by Quarter for Veradigm (NASDAQ:MDRX)

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.